Supplementary Table 1: Calcineurin-Sensitive Genes

Total Page:16

File Type:pdf, Size:1020Kb

Supplementary Table 1: Calcineurin-Sensitive Genes Supplementary Table 1: Calcineurin-Sensitive Genes Supplementary Table 1: Upregulated with Calcineurin (pages 1 -10)- genes that were significant by ANOVA as well as significantly increased in calcineurin- infected cells (Ad-aCaN) compared to 'infected control' (Ad-LacZ). Downregulated with Calcineurin (pages 10 - 17) as above except for direction of change. Columns: Probe Set- Affymetrix probe set identifier for RG-U34A microarray, Symbol (bold font- aCaN significantly different from both LacZ and Uninfected, normal font- aCaN different from LacZ) and Title- annotated information for above probe set (annotation downloaded June, 2004), ANOVA- p-value for 1-way Analysis of Variance, Uninfected, Ad-LacZ and Ad-aCaN- mean ± SEM expression for uninfected control, adenovirus mediated LacZ treated control, and adenovirus mediated calcineurin treated cultures respectively. Upregulated with Calcineurin Probe Set Symbol Title ANOVA Uninfected Ad-LacZ Ad-aCaN rc_AI639448_at A5D3 A5D3 protein 0.00005 713 ± 58 352 ± 54 831 ± 64 J05029_s_at Acadl acetyl-Coenzyme A dehydrogenase, long-chain 0.00000 1105 ± 71 483 ± 46 863 ± 37 J05030_at Acads short chain acyl-coenzyme A dehydrogenase 0.01217 515 ± 40 367 ± 25 513 ± 37 D30647_at Acadvl acyl-Coenzyme A dehydrogenase, very long chain 0.00000 423 ± 21 191 ± 15 271 ± 16 rc_AA900769_s_at Acta2 smooth muscle alpha-actin 0.00246 2629 ± 331 2169 ± 264 4228 ± 466 AJ012603UTR#1_g_at Adam17 a disintegrin and metalloproteinase domain 17 0.00000 435 ± 30 320 ± 49 711 ± 30 M55075_at Adcy3 adenylate cyclase 3 0.04669 1440 ± 95 1207 ± 84 1561 ± 99 L01115_at Adcy6 adenylyl cyclase 6 0.01117 372 ± 24 371 ± 19 467 ± 26 D14909_at Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 0.04816 353 ± 18 313 ± 23 393 ± 22 rc_AA943892_at Agt angiotensinogen 0.00027 703 ± 54 381 ± 37 527 ± 39 U41453_at Akap12 A kinase (PRKA) anchor protein (gravin) 12 0.00008 370 ± 36 513 ± 25 627 ± 34 J03190_at Alas1 aminolevulinic acid synthase 1 0.02469 767 ± 69 626 ± 50 828 ± 29 rc_AI172017_at Aldh2 aldehyde dehydrogenase 2 0.00000 1141 ± 61 531 ± 31 694 ± 21 M73714_at Aldh3a2 aldehyde dehydrogenase family 3, subfamily A2 0.00538 571 ± 26 382 ± 43 525 ± 37 M60322_at Aldr1 Aldehyde reductase 1 (low Km aldose reductase) 0.00000 4596 ± 136 4890 ± 143 6605 ± 166 U89905_at Amacr alpha-methylacyl-CoA racemase 0.04540 580 ± 32 509 ± 33 620 ± 25 U90888_at Ampd3 Adenosine monophosphate deaminase 3 0.00075 79 ± 4 45 ± 11 89 ± 5 AF030089UTR#1_at Ania4 activity and neurotransmitter-induced early gene protein 4 (ania-4) 0.00000 10145 ± 340 4640 ± 374 6078 ± 440 D32209_at Anp32a acidic nuclear phosphoprotein 32 family, member A 0.04959 2743 ± 119 2585 ± 247 3214 ± 159 S57478cds_s_at Anxa1 annexin 1 0.00001 852 ± 83 668 ± 22 1236 ± 64 L13039_s_at Anxa2 calpactin I heavy chain 0.00000 1218 ± 84 1274 ± 60 2896 ± 104 rc_AI171167_at Anxa4 ZAP 36/annexin IV 0.02526 175 ± 22 141 ± 21 226 ± 19 X86086_g_at Anxa6 annexin VI 0.00748 1919 ± 89 1873 ± 105 2237 ± 56 L07074_at Ap3m2 adaptor-related protein complex 3, mu 2 subunit 0.00357 3673 ± 86 3175 ± 61 3499 ± 100 AF029109_at Apba3 amyloid beta (A4) precursor protein-binding, family A, member 3 (X11-like 2) 0.01137 238 ± 19 205 ± 22 302 ± 22 X04979_at Apoe apolipoprotein E 0.00000 21633 ± 889 6150 ± 971 14467 ± 1369 U14007_at Aqp4 aquaporin 4 0.00000 1579 ± 176 310 ± 55 1088 ± 79 AF026505_at Argbp2 Arg/Abl-interacting protein ArgBP2 0.00002 1022 ± 24 663 ± 38 818 ± 44 X77235_at Arl4 ADP-ribosylation-like 4 0.00705 1854 ± 72 1470 ± 123 1901 ± 78 M63282_at Atf3 Activating transcription factor 3 0.00000 440 ± 54 1008 ± 42 1218 ± 47 D89514_at Atic 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP 0.00001 1259 ± 71 1024 ± 101 1827 ± 86 rc_AI177026_at Atp1a2 ATPase, Na+K+ transporting, alpha 2 0.00000 2821 ± 97 371 ± 69 722 ± 76 D84450_at Atp1b3 ATPase, Na+/K+ transporting, beta 3 polypeptide 0.00001 5623 ± 180 4600 ± 177 6063 ± 136 J04024_at Atp2a2 ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 0.00000 382 ± 22 173 ± 12 354 ± 21 rc_AI170268_at B2m Beta-2-microglobulin 0.00000 5666 ± 226 5071 ± 520 8985 ± 195 Page 1 Supplementary Table 1: Calcineurin-Sensitive Genes Probe Set Symbol Title ANOVA Uninfected Ad-LacZ Ad-aCaN rc_H31839_at Bak1 BCL2-antagonist/killer 1 0.00010 512 ± 31 621 ± 53 832 ± 42 U17834_at Bgn biglycan 0.00011 1535 ± 77 952 ± 91 1306 ± 55 rc_AI102299_s_at Bid3 BH3 interacting domain 3 0.00721 1323 ± 44 1390 ± 148 1791 ± 94 X58830_at Bmp6 bone morphogenetic protein 6 0.00001 573 ± 26 562 ± 50 932 ± 55 M60921_g_at Btg2 B-cell translocation gene 2 0.01144 804 ± 75 759 ± 46 1018 ± 56 AF087037_at Btg3 B-cell translocation gene 3 0.00118 542 ± 31 638 ± 33 760 ± 40 D88250_at C1s complement component 1, s subcomponent 0.00000 320 ± 22 354 ± 67 909 ± 61 M29866_s_at C3 Complement component 3 0.00000 26 ± 12 662 ± 133 1932 ± 229 X58294_at Ca2 carbonic anhydrase 2 0.00004 1033 ± 65 662 ± 22 859 ± 33 rc_AI102839_at Calb1 calbindin 1 0.00001 298 ± 27 99 ± 15 168 ± 18 M11597_at Calca calcitonin/calcitonin-related polypeptide, alpha 0.00000 65 ± 7 107 ± 9 143 ± 8 rc_AI180288_s_at Cald1 Caldesmon 1 0.00009 352 ± 46 288 ± 34 597 ± 45 rc_AA892470_at Calm1 Calmodulin 1 (phosphorylase kinase, delta) 0.00000 1674 ± 53 802 ± 77 1210 ± 46 rc_AA894330_s_at Camk2d calcium/calmodulin-dependent protein kinase II, delta 0.00003 1458 ± 53 1286 ± 97 1885 ± 67 rc_AI171796_at Capn6 calpain 6 0.03391 266 ± 19 234 ± 21 316 ± 22 U10071_at Cart cocaine and amphetamine regulated transcript 0.00034 54 ± 15 94 ± 27 177 ± 14 Z46614cds_at Cav caveolin 0.00003 629 ± 65 530 ± 31 917 ± 44 X95986mRNA#1_f_at Cbr1 carbonyl reductase 1 0.00003 727 ± 41 775 ± 64 1133 ± 51 D14014_g_at Ccnd1 cyclin D1 0.02833 685 ± 51 560 ± 45 718 ± 27 rc_AA899106_at Ccnd2 cyclin D2 0.00000 10436 ± 402 3899 ± 268 6103 ± 268 rc_AA800005_at Cd151 CD151 antigen 0.00001 3130 ± 124 2386 ± 261 3901 ± 95 M61875_s_at Cd44 CD44 antigen 0.00764 735 ± 68 602 ± 101 1033 ± 94 X13016_at Cd48 CD48 antigen 0.00000 1054 ± 91 186 ± 23 470 ± 26 X61654_at Cd63 CD63 antigen 0.00000 9308 ± 219 6436 ± 347 9999 ± 349 rc_AI103957_g_at Cd81 CD 81 antigen 0.00000 16305 ± 183 10908 ± 412 13911 ± 410 X76489cds_g_at Cd9 CD9 antigen (p24) 0.00000 3049 ± 317 1002 ± 115 4081 ± 271 AF052695_at Cdc20 cell cycle protein p55CDC 0.00000 391 ± 19 153 ± 16 218 ± 16 X60767mRNA_s_at Cdc2a cell division cycle 2 homolog A (S. pombe) 0.00000 568 ± 36 165 ± 11 252 ± 14 U24174_at Cdkn1a cyclin-dependent kinase inhibitor 1A 0.00000 1419 ± 69 1498 ± 59 2056 ± 75 X60769mRNA_at Cebpb CCAAT/enhancer binding protein (C/EBP), beta 0.00000 1287 ± 99 1672 ± 97 2183 ± 80 M65149_at Cebpd CCAAT/enhancerbinding, protein (C/EBP) delta 0.00402 709 ± 28 401 ± 69 715 ± 75 D14437_s_at Cnn1 Calponin 1 0.00165 129 ± 23 210 ± 38 345 ± 42 rc_AA944422_at Cnn3 calponin 3, acidic 0.00000 9697 ± 503 5305 ± 247 10040 ± 321 rc_AA892559_at Cntf Ciliary neurotropic factor 0.00003 498 ± 53 269 ± 31 587 ± 30 D38492_at Cntn1 contactin 1 0.01582 4014 ± 293 3480 ± 375 4696 ± 167 AJ005396_at Col11a1 procollagen, type XI, alpha 1 0.00402 335 ± 58 133 ± 14 282 ± 29 U57362_at Col12a1 procollagen, type XII, alpha 1 0.00000 209 ± 10 216 ± 12 311 ± 12 M27207mRNA_s_at Col1a1 collagen, type 1, alpha 1 0.00195 3096 ± 419 1945 ± 180 3971 ± 371 rc_AA866454_at Col1a2 procollagen, type I, alpha 2 0.01559 395 ± 21 329 ± 15 392 ± 13 X70369_s_at Col3a1 collagen, type III, alpha 1 0.00001 639 ± 67 552 ± 32 1109 ± 78 rc_AA859757_g_at Col5a1 collagen, type V, alpha 1 0.01757 701 ± 42 735 ± 54 895 ± 46 rc_AI179399_at Col5a2 collagen, type V, alpha 2 0.00000 1050 ± 61 896 ± 65 2544 ± 57 AF001417_s_at Copeb core promoter element binding protein 0.00001 969 ± 51 1318 ± 64 1520 ± 60 X12554cds_s_at Cox6a2 cytochrome c oxidase, subunit VIa, polypeptide 2 0.00117 970 ± 38 727 ± 31 936 ± 46 Page 2 Supplementary Table 1: Calcineurin-Sensitive Genes Probe Set Symbol Title ANOVA Uninfected Ad-LacZ Ad-aCaN L33869_at Cp ceruloplasmin 0.00000 417 ± 52 577 ± 53 1287 ± 63 rc_AA799667_at Cpsf4 cleavage and polyadenylation specific factor 4, 30kD subunit 0.00608 1493 ± 99 1511 ± 156 1970 ± 71 L07736_at Cpt1a carnitine palmitoyltransferase 1 0.00001 1250 ± 71 617 ± 53 916 ± 65 J05470_at Cpt2 Carnitine palmitoyltransferase 2 0.00000 539 ± 25 160 ± 12 332 ± 23 U04835_at Crem cAMP responsive element modulator 0.00016 208 ± 19 184 ± 19 336 ± 26 X60351cds_s_at Cryab crystallin, alpha B 0.00000 1320 ± 140 759 ± 83 2215 ± 128 rc_AI234146_at Csrp1 cysteine rich protein 1 0.00000 1523 ± 89 614 ± 38 1074 ± 47 rc_AI231292_at Cst3 cystatin C 0.00000 36212 ± 1059 17427 ± 1087 29814 ± 1519 M95768_at Ctbs di-N-acetylchitobiase 0.00008 268 ± 19 232 ± 12 348 ± 14 AB010428_s_at Cte1 cytosolic acyl-CoA thioesterase 1 0.00000 1333 ± 100 224 ± 25 422 ± 34 D78591_at Ctf1 cardiotrophin 1 0.02350 325 ± 24 245 ± 20 314 ± 16 D17370_g_at Cth CTL target antigen 0.00029 77 ± 9 96 ± 5 132 ± 9 M38135_at Ctsh Cathepsin H 0.00000 1336 ± 73 463 ± 34 747 ± 30 rc_AI176595_s_at Ctsl Cathepsin L 0.00001 2500 ± 92 2840 ± 99 3515 ± 121 AF022247_at Cubn cubilin 0.00000 106 ± 10 105 ± 19 212 ± 7 U09229_at Cutl1 cut (Drosophila)-like 1 0.01866 597 ± 41 494 ± 31 663 ± 41 U90610_at Cxcr4 Chemokine receptor (LCR1) 0.00000 1992 ± 79 1167 ± 68 1483 ± 73 rc_AI010581_at Dbi diazepam binding inhibitor 0.00000 9334 ± 415 2043 ± 258 2960 ± 124 rc_AI170568_s_at Dci dodecenoyl-coenzyme A delta isomerase 0.00001 510 ± 22 175 ± 33 377 ± 42 L33894_at Dck deoxycytidine kinase 0.01371 147 ± 13 137 ± 13 199 ± 16 L26525_at Ddr1 Discoidin domain receptor family, member 1 0.00376 425 ± 29 344 ± 15
Recommended publications
  • Original Article Upregulation of HOXA13 As a Potential Tumorigenesis and Progression Promoter of LUSC Based on Qrt-PCR and Bioinformatics
    Int J Clin Exp Pathol 2017;10(10):10650-10665 www.ijcep.com /ISSN:1936-2625/IJCEP0065149 Original Article Upregulation of HOXA13 as a potential tumorigenesis and progression promoter of LUSC based on qRT-PCR and bioinformatics Rui Zhang1*, Yun Deng1*, Yu Zhang1, Gao-Qiang Zhai1, Rong-Quan He2, Xiao-Hua Hu2, Dan-Ming Wei1, Zhen-Bo Feng1, Gang Chen1 Departments of 1Pathology, 2Medical Oncology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China. *Equal contributors. Received September 7, 2017; Accepted September 29, 2017; Epub October 1, 2017; Published October 15, 2017 Abstract: In this study, we investigated the levels of homeobox A13 (HOXA13) and the mechanisms underlying the co-expressed genes of HOXA13 in lung squamous cancer (LUSC), the signaling pathways in which the co-ex- pressed genes of HOXA13 are involved and their functional roles in LUSC. The clinical significance of 23 paired LUSC tissues and adjacent non-tumor tissues were gathered. HOXA13 levels in LUSC were detected by quantita- tive real-time polymerase chain reaction (qRT-PCR). HOXA13 levels in LUSC from The Cancer Genome Atlas (TCGA) and Oncomine were analyzed. We performed receiver operator characteristic (ROC) curves of various clinicopath- ological features of LUSC. Co-expressed of HOXA13 were collected from MEM, cBioPortal and GEPIA. The func- tions and pathways of the most reliable overlapped genes were achieved from the Gene Otology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) databases, respectively. The protein-protein interaction (PPI) net- works were mapped using STRING. HOXA13 in LUSC were markedly upregulated compared with those in the non- cancerous controls as demonstrated by qRT-PCR (LUSC: 0.330±0.360; CONTROLS: 0.155±0.142; P=0.021).
    [Show full text]
  • Adenylate Cyclase 3: a New Target for Anti‐Obesity Drug Development
    obesity reviews doi: 10.1111/obr.12430 Obesity Pharmacotherapy Adenylate cyclase 3: a new target for anti-obesity drug development L. Wu,1 C. Shen,2 M. Seed Ahmed,3 C.-G. Östenson4 and H. F. Gu5,6 1Jiangsu Key Laboratory of Drug Screening, Summary China Pharmaceutical University, Nanjing Obesity has become epidemic worldwide, and abdominal obesity has a negative im- 210009, China, 2Department of Epidemiology, pact on health. Current treatment options on obesity, however, still remain limited. School of Public Health, Nanjing Medical It is then of importance to find a new target for anti-obesity drug development University, Nanjing 211166, China, 3Unit for based upon recent molecular studies in obesity. Adenylate cyclase 3 (ADCY3) is Medical Education, Centre for Learning and the third member of adenylyl cyclase family and catalyses the synthesis of cAMP Knowledge, Department of Learning, from ATP. Genetic studies with candidate gene and genome-wide association study Informatics, Management and Ethics, approaches have demonstrated that ADCY3 genetic polymorphisms are associated Karolinska Institutet, Stockholm 17177, with obesity in European and Chinese populations. Epigenetic studies have indi- Sweden, 4Rolf Luft Center for Diabetes cated that increased DNA methylation levels in the ADCY3 gene are involved in Research and Endocrinology, Department of the pathogenesis of obesity. Furthermore, biological analyses with animal models Molecular Medicine and Surgery, Karolinska have implicated that ADCY3 dysfunction resulted in increased body weight and Institutet, Karolinska University Hospital, Solna, fat mass, while reduction of body weight is partially explained by ADCY3 activa- Stockholm 17176, Sweden, 5Department of tion. In this review, we describe genomic and biological features of ADCY3, sum- Clinical Science, Intervention and marize genetic and epigenetic association studies of the ADCY3 gene with obesity Technologies, Karolinska Institutet, Karolinska and discuss dysfunction and activation of ADCY3.
    [Show full text]
  • Circulating Supar in Two Cohorts of Primary FSGS
    CLINICAL RESEARCH www.jasn.org Circulating suPAR in Two Cohorts of Primary FSGS † ‡ Changli Wei,* Howard Trachtman, Jing Li,* Chuanhui Dong, Aaron L. Friedman,§ | | | Jennifer J. Gassman, June L. McMahan, Milena Radeva, Karsten M. Heil,¶ †† ‡‡ Agnes Trautmann,¶ Ali Anarat,** Sevinc Emre, Gian M. Ghiggeri, Fatih Ozaltin,§§ || ††† Dieter Haffner, Debbie S. Gipson,¶¶ Frederick Kaskel,*** Dagmar-Christiane Fischer, ‡‡‡ Franz Schaefer,¶ and Jochen Reiser, for the PodoNet and FSGS CT Study Consortia Departments of *Medicine and ‡Neurology, University of Miami Miller School of Medicine, Miami, Florida; †Department of Pediatrics, NYU Langone Medical Center, New York, New York; §Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota; |Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio; ¶Center for Pediatric and Adolescent Medicine, University of Heidelberg, Heidelberg, Germany; **Department of Pediatric Nephrology, Cukurova University School of Medicine, Adana, Turkey; ††Department of Pediatrics, Istanbul Medical Faculty, University of Istanbul, Istanbul, Turkey; ‡‡Division of Nephrology, Dialysis, and Transplantation, Laboratory on Pathophysiology of Uremia, G. Gaslini Children’s Hospital, Genoa, Italy; §§Pediatric Nephrology Unit, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Turkey; ||Department of Pediatric Kidney, Liver, and Metabolic Diseases, Hannover Medical School, Hannover, Germany; ¶¶Department of Pediatrics, University of Michigan, Ann Arbor, Michigan; ***Children’s Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, New York; †††Department of Pediatrics, Rostock University Hospital, Rostock, Germany; and ‡‡‡Department of Medicine, Rush University Medical Center, Chicago, Illinois ABSTRACT Overexpression of soluble urokinase receptor (suPAR) causes pathology in animal models similar to pri- mary FSGS, and one recent study demonstrated elevated levels of serum suPAR in patients with the disease.
    [Show full text]
  • Discovery of the Novel Autophagy Inhibitor Aumitin That Targets Mitochondrial Complex I
    Electronic Supplementary Material (ESI) for Chemical Science. This journal is © The Royal Society of Chemistry 2018 Discovery of the novel autophagy inhibitor Aumitin that targets mitochondrial complex I Lucas Robkea,b,c, Yushi Futamurad, Georgios Konstantinidise, Julian Wilkea,b, Harumi Aonod, Zhwan Mahmoudb, Nobumoto Watanabec,f, Yao-Wen Wue, Hiroyuki Osadac,d, Luca Laraiaa,g *, Herbert Waldmanna,b * a: Max-Planck-Institute of Molecular Physiology, department of Chemical Biology, Otto-Hahn-Str. 11, 44227 Dortmund (Germany); b: Faculty of Chemistry and Chemical Biology, TU Dortmund University, Otto-Hahn-Str. 4a, 44227 Dortmund (Germany); c: RIKEN-Max Planck Joint Research Division for Systems Chemical Biology, RIKEN CSRS, 2-1, Hirosawa, Wako, Saitama 351-0198 (Japan); d: Chemical Biology Research Group, RIKEN CSRS, 2-1, Hirosawa, Wako, Saitama 351-0198 (Japan); e: Chemical Genomics Centre of the Max-Planck-Society, Otto- Hahn-Str. 15, 44227 Dortmund (Germany); f: Bio-Active Compounds Discovery Research Unit, RIKEN CSRS, 2-1, Hirosawa, Wako, Saitama 351-0198 (Japan). g: present address: Department of Chemistry, Technical University of Denmark, Kemitorvet Building 207, Room 124, 2800 Kgs. Lyngby, Denmark. * luclar@kemi.dtu.dk, herbert.waldmann@mpi-dortmund.mpg.de SI-Table 1: Structure activity relationship of the di-aminopyrimidines. Starvation = starvation induced autophagy assay; Rapamycin = Rapamycin induced autophagy assay; Viability = survival assessed by means of an ADP-glow assay. > 10 = no inhibition at a test concentration of 10
    [Show full text]
  • Transcriptome Analysis of Gravitational Effects on Mouse Skeletal Muscles Under Microgravity and Artificial 1 G Onboard Environm
    www.nature.com/scientificreports OPEN Transcriptome analysis of gravitational efects on mouse skeletal muscles under microgravity and artifcial 1 g onboard environment Risa Okada1,2, Shin‑ichiro Fujita3,4, Riku Suzuki5,6, Takuto Hayashi3,5, Hirona Tsubouchi5, Chihiro Kato5,7, Shunya Sadaki5, Maho Kanai5,6, Sayaka Fuseya3,5, Yuri Inoue3,5, Hyojung Jeon5, Michito Hamada5, Akihiro Kuno5,6, Akiko Ishii8, Akira Tamaoka8, Jun Tanihata9, Naoki Ito10, Dai Shiba1,2, Masaki Shirakawa1,2, Masafumi Muratani1,4, Takashi Kudo1,5* & Satoru Takahashi1,5* Spacefight causes a decrease in skeletal muscle mass and strength. We set two murine experimental groups in orbit for 35 days aboard the International Space Station, under artifcial earth‑gravity (artifcial 1 g; AG) and microgravity (μg; MG), to investigate whether artifcial 1 g exposure prevents muscle atrophy at the molecular level. Our main fndings indicated that AG onboard environment prevented changes under microgravity in soleus muscle not only in muscle mass and fber type composition but also in the alteration of gene expression profles. In particular, transcriptome analysis suggested that AG condition could prevent the alterations of some atrophy‑related genes. We further screened novel candidate genes to reveal the muscle atrophy mechanism from these gene expression profles. We suggest the potential role of Cacng1 in the atrophy of myotubes using in vitro and in vivo gene transductions. This critical project may accelerate the elucidation of muscle atrophy mechanisms. Gravity is the most constant factor afecting the entire process of evolution of organisms on Earth. As adapting to a changing environment is key for any organism’s survival, the constant mechanical stimulus of gravitational force has been shared by all organisms on Earth through evolution 1.
    [Show full text]
  • Calmodulin and Calmodulin-Dependent Protein Kinase II Inhibit Hormone Secretion in Human Parathyroid Adenoma
    31 Calmodulin and calmodulin-dependent protein kinase II inhibit hormone secretion in human parathyroid adenoma Ming Lu1,2,3, Erik Berglund1, Catharina Larsson1,3, Anders Ho¨o¨g4, Lars-Ove Farnebo1 and Robert Bra¨nstro¨m1 1Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital L1:03, SE-171 76 Stockholm, Sweden 2Department of Geriatric Endocrinology, First Affiliated Hospital of Guangxi Medical University, NanNing, People’s Republic of China 3Center for Molecular Medicine (CMM), Karolinska University Hospital, SE-171 76 Stockholm, Sweden 4Department of Oncology–Pathology, Karolinska Institutet, Karolinska University Hospital, SE-171 76 Stockholm, Sweden (Correspondence should be addressed to M Lu at Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital; Email: ming.lu.1@ki.se) Abstract 2C 2C Intracellular calcium ([Ca ]i) is the most relevant modulator adenoma cells in spite of increased [Ca ]i. The inhibitory C of parathyroid hormone (PTH) secretion. Uniquely, an effect of Ca2 calmodulin on PTH secretion may be due to 2C increase in [Ca ]i results in an inhibition of PTH secretion, the absence of synaptotagmin 1 protein in parathyroid and it probably exerts its function via calcium-binding protein adenomas, as demonstrated by western blot analysis. An pathways. The ubiquitous calcium-binding proteins, calmo- increased extracellular calcium level acutely lowered the dulin and calmodulin-dependent protein kinase II (CaMKII), amount of active phosphorylated CaMKII (pCaMKII) in have well-established roles in regulated exocytosis in neurons adenoma cells in vitro, indicating the physiological importance and neuroendocrine cells. However, their roles in parathyroid of this pathway. Moreover, a negative correlation between the cells and PTH secretion are still unclear.
    [Show full text]
  • A New Model for X-Linked Tremor/Ataxia
    © 2016. Published by The Company of Biologists Ltd | Disease Models & Mechanisms (2016) 9, 553-562 doi:10.1242/dmm.022848 RESEARCH ARTICLE Spontaneous shaker rat mutant – a new model for X-linked tremor/ ataxia Karla P. Figueroa1, Sharan Paul1, Tito Calì2, Raffaele Lopreiato2, Sukanya Karan1, Martina Frizzarin2, Darren Ames3, Ginevra Zanni4, Marisa Brini5, Warunee Dansithong1, Brett Milash3, Daniel R. Scoles1, Ernesto Carafoli6 and Stefan M. Pulst1,* ABSTRACT mode of inheritance. Here, we describe the genetic analysis of the The shaker rat is an X-linked recessive spontaneous model of shaker rat, a model of Purkinje cell (PC) degeneration. This mutant progressive Purkinje cell (PC) degeneration exhibiting a shaking arose spontaneously and was observed in Sprague Dawley (SD) ataxia and wide stance. Generation of Wistar Furth (WF)/Brown outbred stock in 1991 at Saint Louis University, first described by Norwegian (BN) F1 hybrids and genetic mapping of F2 sib-sib La Regina et al. (1992), and the phenotype of whole-body tremor, ‘ ’ offspring using polymorphic markers narrowed the candidate gene ataxia and wide stance designated as shaker . The shaker trait was region to 26 Mbp denoted by the last recombinant genetic marker reported as an X-linked recessive trait. DXRat21 at 133 Mbp to qter (the end of the long arm). In the WF Various animal models of spontaneously occurring mutants that background, the shaker mutation has complete penetrance, results in parallel some aspects of human hereditary ataxia have been a stereotypic phenotype and there is a narrow window for age of reported; for example, weaver, lurcher, stumbler, tottering and disease onset; by contrast, the F2 hybrid phenotype was more varied, teetering mice (Chou et al., 1991; Frankel et al., 1994; Green and with a later age of onset and likely non-penetrance of the mutation.
    [Show full text]
  • Somatic and Inherited Mutations in Primary Aldosteronism
    59 1 F L FERNANDES-ROSA, S BOULKROUN Genetic basis of 59: 1 R47–R63 Review and others primary aldosteronism Somatic and inherited mutations in primary aldosteronism Fabio Luiz Fernandes-Rosa1,2,3,*, Sheerazed Boulkroun1,2,* and Maria-Christina Zennaro1,2,3 Correspondence should be addressed 1 INSERM, UMRS_970, Paris Cardiovascular Research Center, Paris, France to F L Fernandes-Rosa or 2 University Paris Descartes, Sorbonne Paris Cité, Paris, France S Boulkroun 3 Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Service de Génétique, Email Paris, France fabio.fernandes-rosa@ *(F L Fernandes-Rosa and S Boulkroun contributed equally to this work) inserm.fr or sheerazed. boulkroun@inserm.fr Abstract Primary aldosteronism (PA), the most common form of secondary hypertension, is caused Key Words in the majority of cases by unilateral aldosterone-producing adenoma (APA) or bilateral f primary aldosteronism adrenal hyperplasia. Over the past few years, somatic mutations in KCNJ5, CACNA1D, f aldosterone-producing ATP1A1 and ATP2B3 have been proven to be associated with APA development, adenoma representing more than 50% of sporadic APA. The identification of these mutations has f familial allowed the development of a model for APA involving modification on the intracellular hyperaldosteronism ionic equilibrium and regulation of cell membrane potential, leading to autonomous f somatic mutations aldosterone overproduction. Furthermore, somatic CTNNB1 mutations have also been f germline mutations identified in APA, but the link between these mutations and APA development remains f potassium channels unknown. The sequence of events responsible for APA formation is not completely f calcium channels understood, in particular, whether a single hit or a double hit is responsible for both f ATPase Journal of Molecular Endocrinology aldosterone overproduction and cell proliferation.
    [Show full text]
  • Regulation of Calmodulin-Stimulated Cyclic Nucleotide Phosphodiesterase (PDE1): Review
    95-105 5/6/06 13:44 Page 95 INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 18: 95-105, 2006 95 Regulation of calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1): Review RAJENDRA K. SHARMA, SHANKAR B. DAS, ASHAKUMARY LAKSHMIKUTTYAMMA, PONNIAH SELVAKUMAR and ANURAAG SHRIVASTAV Department of Pathology and Laboratory Medicine, College of Medicine, University of Saskatchewan, Cancer Research Division, Saskatchewan Cancer Agency, 20 Campus Drive, Saskatoon SK S7N 4H4, Canada Received January 16, 2006; Accepted March 13, 2006 Abstract. The response of living cells to change in cell 6. Differential inhibition of PDE1 isozymes and its environment depends on the action of second messenger therapeutic applications molecules. The two second messenger molecules cAMP and 7. Role of proteolysis in regulating PDE1A2 Ca2+ regulate a large number of eukaryotic cellular events. 8. Role of PDE1A1 in ischemic-reperfused heart Calmodulin-stimulated cyclic nucleotide phosphodiesterase 9. Conclusion (PDE1) is one of the key enzymes involved in the complex interaction between cAMP and Ca2+ second messenger systems. Some PDE1 isozymes have similar kinetic and 1. Introduction immunological properties but are differentially regulated by Ca2+ and calmodulin. Accumulating evidence suggests that the A variety of cellular activities are regulated through mech- activity of PDE1 is selectively regulated by cross-talk between anisms controlling the level of cyclic nucleotides. These Ca2+ and cAMP signalling pathways. These isozymes are mechanisms include synthesis, degradation, efflux and seque- also further distinguished by various pharmacological agents. stration of cyclic adenosine 3':5'-monophosphate (cAMP) and We have demonstrated a potentially novel regulation of PDE1 cyclic guanosine 3':5'- monophosphate (cGMP) within the by calpain.
    [Show full text]
  • Genetics of Migraine: Insights Into the Molecular Basis of Migraine Disorders
    This may be the author’s version of a work that was submitted/accepted for publication in the following source: Sutherland, Heidi& Griffiths, Lyn (2017) Genetics of migraine: Insights into the molecular basis of migraine disor- ders. Headache, 57(4), pp. 537-569. This file was downloaded from: https://eprints.qut.edu.au/105633/ c Consult author(s) regarding copyright matters This work is covered by copyright. Unless the document is being made available under a Creative Commons Licence, you must assume that re-use is limited to personal use and that permission from the copyright owner must be obtained for all other uses. If the docu- ment is available under a Creative Commons License (or other specified license) then refer to the Licence for details of permitted re-use. It is a condition of access that users recog- nise and abide by the legal requirements associated with these rights. If you believe that this work infringes copyright please provide details by email to qut.copyright@qut.edu.au Notice: Please note that this document may not be the Version of Record (i.e. published version) of the work. Author manuscript versions (as Sub- mitted for peer review or as Accepted for publication after peer review) can be identified by an absence of publisher branding and/or typeset appear- ance. If there is any doubt, please refer to the published source. https://doi.org/10.1111/head.13053 Genetics of Migraine: insights into the molecular basis of migraine disorders Heidi G. Sutherland, PhD and Lyn R. Griffiths, PhD Genomics Research Centre, Institute of Health and Biomedical Innovation, QUT, Musk Ave, Kelvin Grove, QLD 4059, Australia The authors declare no conflicts of interest.
    [Show full text]
  • Bioinformatic Analyses in Early Host Response To
    Schroyen et al. BMC Genomics (2016) 17:196 DOI 10.1186/s12864-016-2547-z RESEARCH ARTICLE Open Access Bioinformatic analyses in early host response to Porcine Reproductive and Respiratory Syndrome virus (PRRSV) reveals pathway differences between pigs with alternate genotypes for a major host response QTL Martine Schroyen1†, Christopher Eisley2†, James E. Koltes3, Eric Fritz-Waters1, Igseo Choi4, Graham S. Plastow5, Leluo Guan5, Paul Stothard5, Hua Bao5, Arun Kommadath5, James M. Reecy1, Joan K. Lunney4, Robert R. R. Rowland6, Jack C. M. Dekkers1 and Christopher K. Tuggle1* Abstract Background: AregiononSus scrofa chromosome 4 (SSC4) surrounding single nucleotide polymorphism (SNP) marker WUR10000125 (WUR) has been reported to be strongly associated with both weight gain and serum viremia in pigs after infection with PRRS virus (PRRSV). A proposed causal mutation in the guanylate binding protein 5 gene (GBP5)is predicted to truncate the encoded protein. To investigate transcriptional differences between WUR genotypes in early host response to PRRSV infection, an RNA-seq experiment was performed on globin depleted whole blood RNA collectedon0,4,7,10and14dayspost-infection(dpi)from eight littermate pairs with one AB (favorable) and one AA (unfavorable) WUR genotype animal per litter. Results: Gene Ontology (GO) enrichment analysis of transcripts that were differentially expressed (DE) between dpi across both genotypes revealed an inflammatory response for all dpi when compared to day 0. However, at the early time points of 4 and 7dpi, several GO terms had higher enrichment scores compared to later dpi, including inflammatory response (p <10-7), specifically regulation of NFkappaB (p < 0.01), cytokine, and chemokine activity (p <0.01).At10and 14dpi, GO term enrichment indicated a switch to DNA damage response, cell cycle checkpoints, and DNA replication.
    [Show full text]
  • Expression of Smooth Muscle and Extracellular Matrix Proteins in Relation to Airway Function in Asthma
    Expression of smooth muscle and extracellular matrix proteins in relation to airway function in asthma Annelies M. Slats, MD,a Kirsten Janssen, BHe,a Annemarie van Schadewijk, MSc,a Dirk T. van der Plas, BSc,a Robert Schot, BSc,a Joost G. van den Aardweg, MD, PhD,b Johan C. de Jongste, MD, PhD,c Pieter S. Hiemstra, PhD,a Thais Mauad, MD,d Klaus F. Rabe, MD, PhD,a and Peter J. Sterk, MD, PhDa,e Leiden, Alkmaar, Rotterdam, and Amsterdam, The Netherlands, and Sa˜o Paulo, Brazil Background: Smooth muscle content is increased within the selective expression of airway smooth muscle proteins and airway wall in patients with asthma and is likely to play a role in components of the extracellular matrix. (J Allergy Clin airway hyperresponsiveness. However, smooth muscle cells Immunol 2008;121:1196-202.) express several contractile and structural proteins, and each of these proteins may influence airway function distinctly. Key words: Actin, desmin, elastin, airway smooth muscle, extracel- Objective: We examined the expression of contractile and lular matrix, lung function, hyperresponsiveness, deep inspiration- structural proteins of smooth muscle cells, as well as induced bronchodilation, bronchial biopsies extracellular matrix proteins, in bronchial biopsies of patients with asthma, and related these to lung function, airway hyperresponsiveness, and responses to deep inspiration. Asthma is characterized by chronic airway inflammation, Methods: Thirteen patients with asthma (mild persistent, which is presumed to contribute to variable airways obstruction 1 atopic, nonsmoking) participated in this cross-sectional study. and bronchial hyperresponsiveness. However, recent studies FEV1% predicted, PC20 methacholine, and resistance of the have led to a reappraisal of the role of airway smooth muscle in 2 respiratory system by the forced oscillation technique during asthma pathophysiology.
    [Show full text]